Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × OTHER × Head Neck Cancer Squamous Cell Recurrent × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 3907 Neoplasms 2703 Prostatic Neoplasms 1715 Colorectal Neoplasms 1551 Lung Neoplasms 1377 Carcinoma, Non-Small-Cell Lung 1117 Pancreatic Neoplasms 878 Multiple Myeloma 849 Leukemia, Myeloid, Acute 837 Lymphoma 825 Head and Neck Neoplasms 793 Leukemia 762 Precursor Cell Lymphoblastic Leukemia-Lymphoma 725 Neoplasm Metastasis 693 Colonic Neoplasms 693 Ovarian Neoplasms 683 Carcinoma, Hepatocellular 673 Melanoma 672 Stomach Neoplasms 670 Brain Neoplasms 627 Rectal Neoplasms 624 Lymphoma, Non-Hodgkin 581 Leukemia, Lymphocytic, Chronic, B-Cell 543 Uterine Cervical Neoplasms 530 Glioblastoma 488 Lymphoma, Follicular 486 Hodgkin Disease 479 Esophageal Neoplasms 475 Recurrence 472 Myelodysplastic Syndromes 453

Interventions

Methotrexate 1 Cetuximab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01884623 2024-02-09

ELAN-UNFIT

Gustave Roussy, Cancer Campus, Grand Paris

Phase 3 Completed

Head Neck Cancer Squamous Cell Recurrent

Data powered by HemOnc (CC BY 4.0) Colophon ⚡